Intra-Cellular Therapies Inc. buy BiotechBee
Start price
23.09.22
/
60%
€44.49
Target price
31.07.25
€80.00
Performance (%)
28.12%
End price
05.05.23
€57.00
Summary
This prediction ended on 05.05.23 with a price of €57.00. The prediction had a final performance of 28.12%. BiotechBee has a follow-up prediction for Intra-Cellular Therapies Inc. where he still thinks Intra-Cellular Therapies Inc. is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Intra-Cellular Therapies Inc. | 6.299% | 6.299% | 16.782% |
iShares Core DAX® | -1.670% | -1.001% | 10.864% |
iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
iShares S&P 500 | -2.834% | -0.572% | 25.875% |
According to BiotechBee what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy mit Kursziel 80,0
In the thread Trading Intra-Cellular Therapies Inc.
Buy beendet
Current prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€69.40
19.02.24
19.02.24
€85.00
30.09.25
30.09.25
-3.46%
22:26
22:26
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€58.60
24.06.23
24.06.23
€90.00
30.06.26
30.06.26
18.43%
19.02.24
19.02.24
Could be very worthwhile Investment >20% year